Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Phase III prospective randomised study : curare vs placebo, comparing bowel peristalsis (abdominal echography) in the first minutes of after general anesthesia induction.
Primary End Point: proportion of patients with a score of motion = 0
Primary End Point Proportion of patients with a score of motion = 0
Secondary End Point Time at which thumb adductor twitch measurement disappears (3rd consecutive measure with a twitch at 0) Mean minimal twitch measurement for those patients in who twitch measurement does not disappear Concordance study between twitch measurement and bowel peristalsis XML File Identifier: 1vUwHz2uUXeSc7soLu1cQwRAfcM= Page 15/24 ultrasound score.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Atracurium | Experimental | injection of NMBA 0.5 mg/kg milligram(s)/kilogram in Intravenous bolus use |
|
| ROCURONIUM | Experimental | injection of NMBA 0.6 mg/kg milligram(s)/kilogram in Intravenous bolus |
|
| placebo | Placebo Comparator | injection of placebo Injection in Intravenous bolus use |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| injection of placebo | Drug | 0.5 mg/kg milligram(s)/kilogram |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of patients with a score of motion = 0 | Proportion of patients with a score of motion = 0 | 10 minutes after NMBA or placebo injection |
| Measure | Description | Time Frame |
|---|---|---|
| Time at which thumb adductor twitch measurement disappears | Time at which thumb adductor twitch measurement disappears (3rd consecutive measure with a twitch at 0). Mean minimal twitch measurement for those patients in who twitch measurement does not disappear. Concordance study between twitch measurement and bowel peristalsis | 1 month after injection |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Counter indication to NMBA:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guillaume Taylor | Fondation Ophtalmologique Adolphe de Rothschild | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fondation Ophtalmologique Adolphe de Rothschild | Paris | 75019 | France |
Not provided
| ID | Term |
|---|---|
| D004194 | Disease |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| injection of NMBA |
| Drug |
|
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |